Drug recall · April 23, 2025
Testosterone Cypionate Injection recall
Why: cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Testosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Single-Dose Vial, Distributed by Eugia US LLC, E. Windsor, NJ, Manufactured by: Eugia Specialties Limited, Telangana State, India, NDC 55150-277-01
- Lots / codes
Lot #: 1TC24075A, Exp 11/30/2026.
- Quantity
- 36,816 vials
- Company
- Eugia US LLC, East Windsor, NJ
- Distribution
- Nationwide USA
- Initiated
- April 10, 2025 · Voluntary: Firm initiated
- Classified
- April 14, 2025
- Reported
- April 23, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Testosterone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.